Pelthos Therapeutics PTHS
NYSE PTHS
$25.51 -1.15 (-4.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Return on Assets (QoQ) (2024 - 2026)

Pelthos Therapeutics (PTHS) Return on Assets (QoQ) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Pelthos Therapeutics 91.09 Mn 66.53 Mn 21.23 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 2.00
Jun 30, 2025 4.00
Mar 31, 2025 -2.00
Dec 31, 2024 0.00
Sep 30, 2024 -1.00
Jun 30, 2024 1.00